At what enterprise value was AVIDITY SCIENCE acquired in 2023?

During the acquisition of AVIDITY SCIENCE by ATS CORPORATION in 2023, the company was valued at an estimated revenue multiple of below 5x. The transaction's Enterprise Value is estimated to be in the range of 100M - 350M USD. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Industry & Manufacturing industry currently tracks an average EBITDA multiple of 11.2x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of AVIDITY SCIENCE when it was acquired by ATS CORPORATION?

The estimated EV/EBITDA multiple for AVIDITY SCIENCE is in the range of 10x - 18x. For comparison, the Industry & Manufacturing sector currently shows an average EBITDA multiple of 11.2x. Join our community for free to access full valuation data and industry trends.

When was AVIDITY SCIENCE acquired by ATS CORPORATION?

AVIDITY SCIENCE was acquired by ATS CORPORATION in 2023.

What was the revenue of AVIDITY SCIENCE at the time of the deal?

The revenue of AVIDITY SCIENCE at the time of the deal is estimated to be in the range of 50M - 100M USD. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of AVIDITY SCIENCE during the acquisition?

AVIDITY SCIENCE's EBITDA is estimated to be in the range of 5M - 25M USD. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the AVIDITY SCIENCE acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the AVIDITY SCIENCE deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.avidityscience.com/news/news/ats-completes-acquisition-of-avidity-science

← DATABASE

Home Database Industry & ManufacturingAVIDITY SCIENCE

11/2023

AVIDITY SCIENCE acquired by ATS CORPORATION

UNITED STATES Industrial Equipment / Special Machinery / Lab & Scientific Equipment EV 100M - 350M USD

Context

ATS Corporation has successfully finalized the acquisition of 100% of Avidity Science, integrating the entity into its growing Life Sciences platform. This strategic transaction is designed to establish a comprehensive suite of laboratory automation and water purification technologies, significantly enhancing the group's ability to serve global biomedical research facilities. The strategic rationale for the move centers on the high degree of technical complementarity between the target’s specialized water systems and the group's existing automation and fluid handling capabilities. By incorporating the target’s established customer base and proprietary filtration solutions, the organization bolsters its value proposition as a primary provider of mission-critical lab infrastructure. The partnership is focused on leveraging the group's global aftermarket service network to drive recurring revenue from consumables and maintenance services. This integration reinforces the organization’s standing as a leading enabler of technical innovation in the life sciences sector, providing the strategic depth required to support high-growth biopharmaceutical research and diagnostics applications worldwide. This move marks a significant densification of the group's presence in the scientific fluid management landscape.

AVIDITY SCIENCE, which reported an EBITDA margin of LOGIN in 2023, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a level LOGIN the average currently observed in the Industry & Manufacturing sector (11.2x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Industry & Manufacturing market trends

Target

Avidity Science is a specialized technology organization dedicated to the design and manufacturing of automated water purification solutions and high-precision delivery systems for the biomedical and life science markets. The entity’s business model is centered on providing critical infrastructure for research laboratories, where water quality is a fundamental requirement for experimental integrity. Its value proposition lies in the integration of advanced filtration technology with digital monitoring and automated distribution, ensuring technical durability and operational safety in high-stakes clinical environments. Strategically, the firm focuses on the convergence of fluid management and lab automation, facilitating the transition toward "smart" connected laboratories. By maintaining a robust portfolio of proprietary technologies, the organization ensures a mission-critical role in global pharmaceutical research and animal healthcare sectors. The firm prioritizes technical innovation to meet increasingly rigorous regulatory standards in the global life sciences landscape.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (USD)

Year

Rev

EBITDA

EBIT

2023

2022

Similar deals in Industry & Manufacturing

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
01/2024	STANDARD BIOTOOLS	SOMALOGIC	UNITED STATES	Industrial Equipment	The merger between Standard BioTools and SomaLogic creates a diversified and scaled leader in the life sciences tools industry. The strategic rationale for this transaction centers on a "multi-omic integration" play, merging the target's technical operational depth in proteomics with the group's established mass cytometry and microfluidics platforms
12/2023	ENPRO	ADVANCED MICRO INSTRUMENTS	UNITED STATES	Industrial Equipment	The successful acquisition of Advanced Micro Instruments (AMI) by Enpro Inc. marks a decisive tactical expansion of the group’s capabilities within the compositional analysis market. This transaction facilitates the integration of Advanced Micro Instruments' proprietary sensing technologies into Enpro Inc
11/2023	GEORG FISCHER	UPONOR	FINLAND	Industrial Equipment	Achieving a significant milestone in its industrial consolidation strategy, Georg Fischer has finalized the acquisition of a controlling stake in Uponor. This public tender offer marks a transformative step in creating a global leader in sustainable water and flow solutions, effectively combining two highly complementary technical portfolios
11/2023	LIFCO	GREEN INSTRUMENTS	DENMARK	Industrial Equipment	Green Instruments has been acquired by Lifco. The strategic rationale for the move centers on the industrial synergy between Green Instruments' market-leading position in IMO-compliant monitoring systems and Lifco’s established expertise in scaling niche technical leaders through a decentralized operating model
11/2023	OXFORD METRICS	INDUSTRIAL VISION SYSTEMS	UNITED KINGDOM	Industrial Equipment	The successful acquisition of Industrial Vision Systems Ltd by Oxford Metrics signals a significant tactical expansion of the group’s "sense, analyse and apply" strategy. This transaction facilitates the integration of specialized machine learning and AI-driven quality control software into Oxford Metrics’ broader smart sensing portfolio
11/2023	PATELEC GROUP	PHOENIX ELECTRONIC SYSTEM	ITALY	Industrial Equipment	Patelec Group has acquired a majority stake in Phoenix Electronic System to expand its product range into industrial wiring harnesses and electrical cabinets. The operation is meticulously structured to maintain the target's operational autonomy while deeply integrating its specialized product offerings to generate substantial cross-selling synergies
10/2023	FORTIVE CORPORATION	EA ELEKTRO-AUTOMATIK	GERMANY	Industrial Equipment	The acquisition of EA Elektro-Automatik by Fortive represents a definitive tactical expansion of the group's presence within the high-power electronic testing market. This transaction facilitates the integration of EA Elektro-Automatik’s programmable power solutions into Fortive’s Precision Technologies segment, specifically complementing the existing Tektronix franchise
10/2023	HALMA	ALPHA INSTRUMATICS	UNITED KINGDOM	Industrial Equipment	The successful acquisition of Alpha Instrumatics represents a tactical expansion of Halma’s analytical instrumentation capabilities within its Environmental & Analysis segment. This transaction marks the integration of Alpha Instrumatics’ highly specialized trace moisture detection technology, effectively widening the technical operational depth available to Alicat Scientific’s global industrial gas and energy transition customers
10/2023	EMERSON	NATIONAL INSTRUMENTS CORPORATION	UNITED STATES	Industrial Equipment	In October 2023, Emerson completed the acquisition of National Instruments (NI), marking a significant strategic milestone in the industrial automation and test and measurement technologies sector. This acquisition aligns with Emerson's strategy to bolster its global position in industrial software and connected solutions
10/2023	TELEDYNE TECHNOLOGIES INCORPORATED	XENA NETWORKS	DENMARK	Industrial Equipment	The acquisition of Xena Networks by Teledyne marks a definitive tactical expansion of the group’s protocol test portfolio into the high-growth Terabit Ethernet market. This transaction facilitates the integration of Xena Networks’ traffic generation and network emulation capabilities into Teledyne LeCroy’s existing protocol analysis platform, creating a unique end-to-end verification solution

REFERENCES

Valuation range: EV 100M - 350M USD

Revenue range: 50M - 100M USD

EBITDA range: 5M - 25M USD

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of AVIDITY SCIENCE by ATS CORPORATION are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).